These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
641 related items for PubMed ID: 26337869
1. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells. Zhou D, Wan Y, Xie D, Wang Y, Wei J, Yan Q, Lu P, Mo L, Xie J, Yang S, Qi X. Exp Mol Med; 2015 Sep 04; 47(9):e182. PubMed ID: 26337869 [Abstract] [Full Text] [Related]
2. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression. Wei J, Qi X, Zhan Q, Zhou D, Yan Q, Wang Y, Mo L, Wan Y, Xie D, Xie J, Yang S. Biomed Pharmacother; 2015 Apr 04; 71():112-8. PubMed ID: 25960225 [Abstract] [Full Text] [Related]
3. Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide. Kan W, Gao L, Chen J, Chen L, Zhang G, Hao B, He M, Chen X, Wang C. Mol Neurobiol; 2024 Sep 04; 61(9):7066-7074. PubMed ID: 38368287 [Abstract] [Full Text] [Related]
4. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death. Chen PH, Cheng CH, Shih CM, Ho KH, Lin CW, Lee CC, Liu AJ, Chang CK, Chen KC. PLoS One; 2016 Sep 04; 11(11):e0167096. PubMed ID: 27893811 [Abstract] [Full Text] [Related]
6. Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide. Li H, Yuan X, Yan D, Li D, Guan F, Dong Y, Wang H, Liu X, Yang B. Cell Physiol Biochem; 2017 Sep 04; 42(3):1192-1201. PubMed ID: 28668966 [Abstract] [Full Text] [Related]
8. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma. Tian T, Mingyi M, Qiu X, Qiu Y. Oncotarget; 2016 Nov 29; 7(48):79584-79595. PubMed ID: 27792996 [Abstract] [Full Text] [Related]
9. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24. Chen M, Cheng Y, Yuan Z, Wang F, Yang L, Zhao H. Cancer Biother Radiopharm; 2020 Mar 29; 35(2):101-108. PubMed ID: 31750728 [Abstract] [Full Text] [Related]
10. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells. Han J, Chen Q. Int J Clin Exp Pathol; 2015 Mar 29; 8(10):12698-707. PubMed ID: 26722459 [Abstract] [Full Text] [Related]
11. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. Wang J, Sai K, Chen FR, Chen ZP. Cancer Chemother Pharmacol; 2013 Jul 29; 72(1):147-58. PubMed ID: 23645289 [Abstract] [Full Text] [Related]
18. MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1. Wu H, Liu Q, Cai T, Chen YD, Liao F, Wang ZF. Diagn Pathol; 2014 Sep 30; 9():173. PubMed ID: 25266957 [Abstract] [Full Text] [Related]
19. LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway. Du P, Zhao H, Peng R, Liu Q, Yuan J, Peng G, Liao Y. Biosci Rep; 2017 Oct 31; 37(5):. PubMed ID: 28831025 [Abstract] [Full Text] [Related]